EMEA-002959-PIP01-21
Key facts
| Active substance |
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0208/2021
|
| PIP number |
EMEA-002959-PIP01-21
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of migraine headaches
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Orion Corporation
E-mail: orionra@orionpharma.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|